552 related articles for article (PubMed ID: 33968677)
41. Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression.
Ferlizza E; Romaniello D; Borrelli F; Pagano F; Girone C; Gelfo V; Kuhre RS; Morselli A; Mazzeschi M; Sgarzi M; Filippini DM; D'Uva G; Lauriola M
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296932
[TBL] [Abstract][Full Text] [Related]
42. Detection of Extracellular Vesicle-Derived RNA as Potential Prostate Cancer Biomarkers: Role of Cancer-type SLCO1B3 and ABCC3.
Lee KY; Beatson EL; Knechel MA; Sommer ER; Napoli GC; Risdon EN; Leon AF; Depaz RD; Strope JD; Price DK; Chau CH; Figg WD
J Cancer; 2024; 15(3):615-622. PubMed ID: 38213719
[TBL] [Abstract][Full Text] [Related]
43. The Role of Extracellular Vesicles in Disease Progression and Detection of Hepatocellular Carcinoma.
Lee YT; Tran BV; Wang JJ; Liang IY; You S; Zhu Y; Agopian VG; Tseng HR; Yang JD
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34203086
[TBL] [Abstract][Full Text] [Related]
44. Extracellular vesicles as drivers of epithelial-mesenchymal transition and carcinogenic characteristics in normal prostate cells.
Souza AG; B Silva IB; Campos-Fernández E; Marangoni K; F Bastos VA; Alves PT; Goulart LR; Alonso-Goulart V
Mol Carcinog; 2018 Apr; 57(4):503-511. PubMed ID: 29247548
[TBL] [Abstract][Full Text] [Related]
45. Extracellular Vesicles and Circulating Tumour Cells - complementary liquid biopsies or standalone concepts?
Słomka A; Wang B; Mocan T; Horhat A; Willms AG; Schmidt-Wolf IGH; Strassburg CP; Gonzalez-Carmona MA; Lukacs-Kornek V; Kornek MT
Theranostics; 2022; 12(13):5836-5855. PubMed ID: 35966579
[TBL] [Abstract][Full Text] [Related]
46. Extracellular Vesicle-Dependent Cross-Talk in Cancer-Focus on Pancreatic Cancer.
Nannan L; Oudart JB; Monboisse JC; Ramont L; Brassart-Pasco S; Brassart B
Front Oncol; 2020; 10():1456. PubMed ID: 32974169
[TBL] [Abstract][Full Text] [Related]
47. Cell Stress Induced Stressome Release Including Damaged Membrane Vesicles and Extracellular HSP90 by Prostate Cancer Cells.
Eguchi T; Sogawa C; Ono K; Matsumoto M; Tran MT; Okusha Y; Lang BJ; Okamoto K; Calderwood SK
Cells; 2020 Mar; 9(3):. PubMed ID: 32204513
[TBL] [Abstract][Full Text] [Related]
48. Surface-Engineered Extracellular Vesicles in Cancer Immunotherapy.
Johnson V; Vasu S; Kumar US; Kumar M
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345176
[TBL] [Abstract][Full Text] [Related]
49. Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy.
Zhou E; Li Y; Wu F; Guo M; Xu J; Wang S; Tan Q; Ma P; Song S; Jin Y
EBioMedicine; 2021 May; 67():103365. PubMed ID: 33971402
[TBL] [Abstract][Full Text] [Related]
50. Bioengineered Exosomal Extracellular Vesicles in Cancer Therapeutics.
Miles J; Andre M; Caobi A; Ruiz M; Nair M; Raymond AD
Crit Rev Biomed Eng; 2020; 48(3):177-187. PubMed ID: 33389895
[TBL] [Abstract][Full Text] [Related]
51. The role and potential application of extracellular vesicles in liver cancer.
Qi X; Chen S; He H; Wen W; Wang H
Sci China Life Sci; 2021 Aug; 64(8):1281-1294. PubMed ID: 33847910
[TBL] [Abstract][Full Text] [Related]
52. Extracellular vesicles in cancer: challenges and opportunities for clinical laboratories.
González Á; López-Borrego S; Sandúa A; Vales-Gomez M; Alegre E
Crit Rev Clin Lab Sci; 2024 Feb; ():1-23. PubMed ID: 38361287
[TBL] [Abstract][Full Text] [Related]
53. Exploring Small Extracellular Vesicles for Precision Medicine in Prostate Cancer.
Giulietti M; Santoni M; Cimadamore A; Carrozza F; Piva F; Cheng L; Lopez-Beltran A; Scarpelli M; Battelli N; Montironi R
Front Oncol; 2018; 8():221. PubMed ID: 29951374
[TBL] [Abstract][Full Text] [Related]
54. Multidrug resistant tumour cells shed more microvesicle-like EVs and less exosomes than their drug-sensitive counterpart cells.
Lopes-Rodrigues V; Di Luca A; Sousa D; Seca H; Meleady P; Henry M; Lima RT; O'Connor R; Vasconcelos MH
Biochim Biophys Acta; 2016 Mar; 1860(3):618-27. PubMed ID: 26708992
[TBL] [Abstract][Full Text] [Related]
55. Extracellular Vesicles for Childhood Cancer Liquid Biopsy.
Singhto N; Pongphitcha P; Jinawath N; Hongeng S; Chutipongtanate S
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730633
[TBL] [Abstract][Full Text] [Related]
56. Enabling Sensitive Phenotypic Profiling of Cancer-Derived Small Extracellular Vesicles Using Surface-Enhanced Raman Spectroscopy Nanotags.
Zhang W; Jiang L; Diefenbach RJ; Campbell DH; Walsh BJ; Packer NH; Wang Y
ACS Sens; 2020 Mar; 5(3):764-771. PubMed ID: 32134252
[TBL] [Abstract][Full Text] [Related]
57. Exosomes and extracellular vesicles: Rethinking the essential values in cancer biology.
Yokoi A; Ochiya T
Semin Cancer Biol; 2021 Sep; 74():79-91. PubMed ID: 33798721
[TBL] [Abstract][Full Text] [Related]
58. Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes.
Nimir M; Ma Y; Jeffreys SA; Opperman T; Young F; Khan T; Ding P; Chua W; Balakrishnar B; Cooper A; De Souza P; Becker TM
Cells; 2019 Jul; 8(7):. PubMed ID: 31288377
[TBL] [Abstract][Full Text] [Related]
59. Anti-Cancer Role and Therapeutic Potential of Extracellular Vesicles.
Tominaga N
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944923
[TBL] [Abstract][Full Text] [Related]
60. An update on extracellular vesicles in multiple myeloma: a focus on their role in cell-to-cell cross-talk and as potential liquid biopsy biomarkers.
De Luca L; Laurenzana I; Trino S; Lamorte D; Caivano A; Musto P
Expert Rev Mol Diagn; 2019 Mar; 19(3):249-258. PubMed ID: 30782029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]